Basiliximab Maintenance in Ulcerative Colitis

Clinical trial NCT01061996 · TERMINATED

Trial details

NCT number: NCT01061996
Sponsor: Cerimon Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2007-07-01
Primary completion: 2008-12-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.